Delcath Systems, an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, has entered into a debt facility with Avenue Venture Opportunities Fund, providing up to $20 million with an initial $15 million funded at close. Read more.
Related Posts
Struggling Hazel Hawkins Seeks $10M Credit Line
A consulting firm said even the line of credit might not be enough to save the hospital.
May 4, 2023
VIUM Capital Exceeds $1B in Deals After ‘Wild Ride’
The firm recently passed $1 billion in closed senior housing and health care financings.
December 1, 2021
Cohen Foundation Gifts $35M to NewYork-Presbyterian Pediatric Behavioral Health Unit
According to NewYork-Presbyterian, the funds will be used to expand child and adolescent inpatient units and create a state-of-the-art ambulatory behavioral health center at NewYork-Presbyterian Westchester Behavioral Health in White Plains.
July 10, 2023
AAP Receives $7.5M Grant to Address Integrated Care for Adolescents, Young Adults
The Maternal and Child Health Bureau, housed under the Health Resources and Services Administration, made the investment.
November 15, 2023